Bill Sheridan

(Dr. William Sheridan)

Currently holds a position at BioCryst Pharmaceuticals Inc

Positions
Position Company Period
Senior Vice President, Chief Medical Officer BioCryst Pharmaceuticals Inc July 1, 2008 -
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2022-03-14 2022-03-10
S Sale
1,400 -3.6%
17.64
24,696 USD 		1,400 -3.6% 17.64 24,696 USD
2022-03-14 2022-03-10
S Sale
159,739 -80.2%
16.87
2,694,797 USD 		159,739 -80.2% 16.87 2,694,797 USD
2021-06-01 2021-05-28
PS Planned sale
91,814 -86.4%
15.02
1,379,046 USD 		91,814 -86.4% 15.02 1,379,046 USD
2021-06-01 2021-05-27
PS Planned sale
71,759 -83.2%
15.00
1,076,385 USD 		71,759 -83.2% 15.00 1,076,385 USD
2021-02-24 2021-02-22
PS Planned sale
41,250 -78.2%
11.57
477,263 USD 		41,250 -78.2% 11.57 477,263 USD